SELECTION OF MOLECULAR FRAGMENT FEATURES FOR STRUCTURE-ACTIVITY STUDIES IN
ANTITUMOUR SCREENING.
     
THE NATIONAL CANCER INSTITUTE DEVELOPMENTAL THERAPEUTICS PROGRAM SCREENS ABOUT
13,000 COMPOUNDS PER YEAR FOR ANTITUMOUR ACTIVITY IN A MOUSE PRESCREEN. A
METHOD FOR PREDICTING ACTIVITY USES MOLECULAR FRAGMENT FEATURES OF POTENTIAL
ACQUISITIONS. THIS PAPER COVERS SOME DETAILS ABOUT HOW THE SET OF FEATURES WAS
CHOSEN, FILLING A GAP IN EARLIER PUBLICATIONS.
